Pre-Conference Day

Moving Beyond CD19 to Identify the Next-Generation of Clinically Viable Targets

With clinical momentum building around CD19-targeted approaches, developers are increasingly exploring novel targets that can address a broader range of indications and enhance safety profiles. Join this interactive workshop to explore emerging approaches for target discovery and the opportunities these targets can enable across autoimmune cell therapy development.

In this workshop, our leaders will be:

• Leveraging AI and computational approaches for identifying novel autoimmune targets
• Establishing preclinical models for validating target selection in autoimmune contexts
• Translating learnings from T-cell engagers and immunology drug development to inform cell therapy target discovery

Exploring Rheumatologic Perspectives on Integrating Cell Therapy into Autoimmune Care

While autoimmune cell therapies advance through clinical development, understanding the realities of treating patients in the clinic has never been more important. This interactive workshop will provide a practical, boots-on-the-ground perspective on designing and running autoimmune cell therapy trials, covering recruitment challenges, care coordination, and generating the long-term evidence needed to support broader adoption.

In this workshop, our leaders will be:

• Highlighting evolving clinical perspectives in rheumatology to contextualize where cell therapy fits across autoimmune indications and treatment pathways
• Examining practical challenges of integrating cell therapies into healthcare systems, including infrastructure, and multidisciplinary collaboration
• Assessing strategies for generating long-term outcomes data through registries to inform clinical decision-making and support scalable adoption of cell therapies